Related Experiment Video

Updated: May 10, 2026

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
09:09

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients

Published on: April 3, 2026

MicroRNAs: Novel diagnostic and prognostic biomarkers in atherosclerosis

Gerasimos Siasos1, Christina Kollia, Vasiliki Tsigkou

  • 1Department of Biological Chemistry, University of Athens Medical School, Athens Greece. gsiasos@med.uoa.gr

Current Topics in Medicinal Chemistry
|June 11, 2013
PubMed

Insights

MicroRNAs (miRNAs) regulate gene expression and are involved in key processes like lipid metabolism and inflammation. This review explores the critical roles of miRNAs in the development and progression of atherosclerosis.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cardiovascular Research

Background:

  • MicroRNAs (miRNAs) are small, non-coding RNAs regulating gene expression post-transcriptionally.
  • They influence mRNA translation or degradation, impacting cellular functions.
  • miRNAs are implicated in various biological processes relevant to atherosclerosis.

Purpose of the Study:

  • To review the multifaceted roles of miRNAs in atherosclerosis.
  • To highlight miRNA involvement in lipid metabolism, inflammation, and plaque development.
  • To consolidate current understanding of miRNA function in cardiovascular disease.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of studies investigating miRNA involvement in atherosclerosis.
  • Synthesis of evidence on miRNA regulatory mechanisms.

Main Results:

  • miRNAs significantly regulate lipid metabolism and inflammatory responses.
  • They play crucial roles in cell cycle, proliferation, and oxidative stress.
  • miRNA involvement is evident in endothelial function, angiogenesis, and plaque rupture.

Conclusions:

  • miRNAs are key regulators in the initiation and progression of atherosclerosis.
  • Targeting specific miRNAs presents potential therapeutic strategies for atherosclerosis.
  • Further research is warranted to fully elucidate miRNA functions in cardiovascular health.

More Related Videos

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease04:41

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...